Nutritional treatment for inborn errors of metabolism: Indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example

Molecular Genetics and Metabolism

Volumn 107, Issue 1-2, 2012, Pages 3-9

  Camp, Kathryn M ^a   Lloyd Puryear, Michele A ^b   Huntington, Kathleen L ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Inborn errors of metabolism; Inherited metabolic disorders; Medical food; Phenylketonuria; PKU; Treatment

Indexed keywords

ACYLCARNITINE; AMINO ACID; VITAMIN;

ACIDEMIA; ACIDURIA; ADOLESCENCE; ARGININOSUCCINIC ACIDURIA; BETA THALASSEMIA; CHILD NUTRITION; CITRULLINEMIA; CONGENITAL ADRENAL HYPERPLASIA; COST BENEFIT ANALYSIS; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISORDERS OF CARBOHYDRATE METABOLISM; ENZYME ACTIVITY; FATTY ACID OXIDATION; FOOD AND DRUG ADMINISTRATION; FOOD AVAILABILITY; GALACTOSEMIA; HEARING LOSS; HOMOCYSTINURIA; HUMAN; INBORN ERROR OF METABOLISM; MAPLE SYRUP URINE DISEASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; METHYLMALONIC ACIDEMIA; NEWBORN SCREENING; PHENYLKETONURIA; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PROPIONIC ACIDEMIA; PUBLIC HEALTH INSURANCE; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SICKLE CELL ANEMIA; TANDEM MASS SPECTROMETRY; TREATMENT FAILURE; TREATMENT INDICATION; TYROSINEMIA; UNITED STATES;

DIET; DIETARY SUPPLEMENTS; HUMANS; METABOLISM, INBORN ERRORS; PHENYLKETONURIAS;

EID: 84866179926     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.07.005     Document Type: Review

References (23)

1. Acosta P.B., Yannicelli S. The Ross Metabolic Formula System, Nutrition Support Protocols 2001, Ross Products Division, Division of Abbott Laboratories, Columbus, Ohio.
2. McCabe L.L., Therrell B.L., McCabe E.R. Newborn screening: rationale for a comprehensive, fully integrated public health system. Mol. Genet. Metab. 2002, 77:267-273.
3. National Conference of State Legislatures Insurance coverage of medically necessary foods and formula to treat disorders identified through newborn screening 2008.
4. National Institutes of Health Consensus Development Panel National Institutes of Health Consensus Development Conference statement: phenylketonuria: screening and management, October 16-18, 2000. Pediatrics 2001, 108:972-982.
5. Weaver M.A., Johnson A., Singh R.H., Wilcox W.R., Lloyd-Puryear M.A., Watson M.S. Medical foods: inborn errors of metabolism and the reimbursement dilemma. Genet. Med. 2010, 12:364-369.
6. Lindegren M., Krishnaswami S., Fonnesbeck C., Reimschisel T., Fisher J., Jackson K., Shields T., Sathe N., McPheeters M. Adjuvant treatment for phenylketonuria (PKU). Comparative Effectiveness Review No. 56. (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. HHSA 290-2007-10065-I.) AHRQ Publication No. 12-EHC035-EF, Rockville, MD 2012.
7. Macleod E.L., Ney D.M. Nutritional management of phenylketonuria. Ann. Nestle Eng. 2010, 68:58-69.
8. Food and Nutrition Board, Institute of Medicine, National Academies Dietary Reference Intakes (DRIs): estimated average requirements 2002/2005.
9. Schuett V.E. Low protein food list for PKU 2010, CreateSpace.
10. Genetic Metabolic Dietitians International, MetabolicPro, 2011.
11. Parisi M., Levy H. NIH PKU Conference Report: State of the Science and Future Research Needs 2012.
12. Evans J.M., Huntington K. PHE for three: a tracking system for 1, 2 and 3 equivalents 1998, Oregon Health and Science University, Portland, Oregon.
13. U.S. Food and Drug Administration Exempt infant formulas marketed in the United States by manufacturer and category 2011.
14. National Archives and Records Administration Title 21: food and drugs, part 107-exempt infant formulas 2010.
15. U.S. Food and Drug Administration Orphan Drug Act-excerpts (Public Law 97-414, as Amended) 2011.
16. U.S. Congress Orphan Drug Amendments of 1988 (Act to Amend the Federal Food, Drug, Cosmetic Act to Revise the Provisions Respecting Orphan Drugs, for Other Purposes). Public Law 100-290 1988, U.S. Government Printing Office, Washington, DC.
17. U.S. Food and Drug Administration Compliance program guidance manual, chapter 21. Food Composition, Standards, Labeling and Economics 2006.
18. U.S. Food and Drug Administration Guidance for industry: frequently asked questions about medical foods 1997.
19. U.S. Food and Drug Administration Registration of Food Facilities 2002.
20. U.S. Food and Drug Administration Dietary Supplements 1994.
21. Huntington K., Buist N.R.M. Medical food for treatment of inborn errors of metabolism and state legislative mandates. Topics in Clinical Nutrition 2009, 24:289-306. (210.1097/TIN.1090b1013e3181c1622e1092).
22. Secretary's Advisory Committee on Heritable Disorders in Newborns and Children Recommended uniform screening panel of the Secretary's Advisory Committee on Heritable Disorders in Newborns and Children 2011.
23. American College of Medical Genetics' Newborn Screening Expert Group Newborn screening: toward a uniform screening panel and system. Genet. Med. 2006, 8(Suppl. 1):1S-252S.